T1	p 21 47	autism spectrum disorder :
T2	p 308 349	autism spectrum disorder ( ASD ) symptoms
T3	p 353 387	children and adolescents with both
T4	p 396 427	attention-deficit/hyperactivity
T5	p 439 447	ADHD ) .
T6	p 456 518	A total of 97 patients 6-17 years of age , with ASD and ADHD ,
T7	i 6 17	Atomoxetine
T8	i 293 304	atomoxetine
T9	i 554 565	atomoxetine
T10	i 596 614	placebo-controlled
T11	i 771 802	Behavior Questionnaire ( CSBQ )
T12	i 855 866	atomoxetine
T13	i 1127 1138	atomoxetine
T14	i 1173 1184	atomoxetine
T15	o 62 80	social functioning
T16	o 110 165	stereotyped behaviors , inappropriate speech , and fear
T17	o 341 349	symptoms
T18	o 428 436	disorder
T19	o 662 674	parent-based
T20	o 702 743	, the Aberrant Behavior Checklist ( ABC )
T21	o 761 800	's Social Behavior Questionnaire ( CSBQ
T22	o 935 1016	the ABC subscales Hyperactivity , Inappropriate Speech , and Stereotypic Behavior
T23	o 1026 1052	the CSBQ subscale Fear for
T24	o 1142 1162	social functioning .
T25	o 1211 1236	and stereotyped behaviors